Mou R - Search Results

1

Anticancer effects of curcumin on nude mice bearing lung cancer A549 cell subsets SP and NSP cells.

Li X, Ma S, Yang P, Sun B, Zhang Y, Sun Y, Hao M, Mou R, Jia Y. Li X, et al. Among authors: mou r. Oncol Lett. 2018 Nov;16(5):6756-6762. doi: 10.3892/ol.2018.9488. Epub 2018 Sep 24. Oncol Lett. 2018. PMID: 30405819 Free PMC article.

2

[Laboratory techniques for the diagnosis of prostate cancer: An update].

Mou RY, Li XJ. Mou RY, et al. Zhonghua Nan Ke Xue. 2017 Apr;23(4):372-375. Zhonghua Nan Ke Xue. 2017. PMID: 29714425 Review. Chinese.

3

Prostate cancer: a risk factor for COVID-19 in males?: A protocol for systematic review and meta analysis.

Mou R, Jin X, Li W, Wu M, Liu X, Liu Z, Guo S, Li X, Jia Y. Mou R, et al. Medicine (Baltimore). 2020 Oct 23;99(43):e22591. doi: 10.1097/MD.0000000000022591. Medicine (Baltimore). 2020. PMID: 33120746 Free PMC article.

4

Is COVID-19 a high risk factor for lung cancer?: A protocol for systematic review and meta-analysis.

Wu M, Mou R, Liu X, Guo S, Kong F, Li X, Jia Y. Wu M, et al. Among authors: mou r. Medicine (Baltimore). 2021 Jan 8;100(1):e23877. doi: 10.1097/MD.0000000000023877. Medicine (Baltimore). 2021. PMID: 33429748 Free PMC article.

5

Hispidulin inhibits proliferation, migration, and invasion by promoting autophagy via regulation of PPARγ activation in prostate cancer cells and xenograft models.

Wang Y, Guo S, Jia Y, Yu X, Mou R, Li X. Wang Y, et al. Among authors: mou r. Biosci Biotechnol Biochem. 2021 Mar 24;85(4):786-797. doi: 10.1093/bbb/zbaa108. Biosci Biotechnol Biochem. 2021. PMID: 33590833

6

EpCAM as a Novel Biomarker for Survivals in Prostate Cancer Patients.

Liao Y, Wu M, Jia Y, Mou R, Li X. Liao Y, et al. Among authors: mou r. Front Cell Dev Biol. 2022 Apr 20;10:843604. doi: 10.3389/fcell.2022.843604. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35517503 Free PMC article.

7

RGN as a prognostic biomarker with immune infiltration and ceRNA in lung squamous cell carcinoma.

Liao Y, Cheng W, Mou R, Li X, Jia Y. Liao Y, et al. Among authors: mou r. Sci Rep. 2023 May 9;13(1):7553. doi: 10.1038/s41598-023-32217-z. Sci Rep. 2023. PMID: 37161020 Free PMC article.

8

Inflammatory bowel disease and prostate cancer risk: a two-sample Mendelian randomization analysis.

Cheng W, Liao Y, Mou R, Xiao X, Jia Y. Cheng W, et al. Among authors: mou r. Front Immunol. 2023 Jun 20;14:1157313. doi: 10.3389/fimmu.2023.1157313. eCollection 2023. Front Immunol. 2023. PMID: 37409117 Free PMC article.

9

Developing a Core Outcome Set for Assessing Clinical Safety Outcomes of Prostate Cancer in Clinical Trials of Traditional Chinese Medicine: Protocol for a Mixed Methods Study.

Tian H, Zhang Y, Ren J, Wang C, Mou R, Li X, Jia Y. Tian H, et al. Among authors: mou r. JMIR Res Protoc. 2023 Aug 7;12:e46794. doi: 10.2196/46794. JMIR Res Protoc. 2023. PMID: 37549007 Free PMC article.

10

Application of organoids in precision immunotherapy of lung cancer (Review).

Tian H, Ren J, Mou R, Jia Y. Tian H, et al. Among authors: mou r. Oncol Lett. 2023 Sep 26;26(5):484. doi: 10.3892/ol.2023.14071. eCollection 2023 Nov. Oncol Lett. 2023. PMID: 37818130 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters